08:00 , Oct 31, 2000 |  BC Extra  |  Financial News

Galileo raises $31 million

Galileo Laboratories raised $31 million in its third round of venture financing through North Castle Partners; H&Q Life Sciences; H&Q Healthcare; Sofinov; The Chatterjee Group; Alloy Ventures; Brinson Partners; Bay City Capital; and CMEA Life...
07:00 , Apr 26, 1999 |  BioCentury  |  Emerging Company Profile

Galileo Laboratories Inc.

Galileo Laboratories Inc. Santa Clara, Calif. Technology: Cell-based screening assays that show effects on energy production and regulation Disease focus: Cardiovascular, diabetes, nutraceuticals Clinical status: Preclinical Founded: 1997 by Guy Miller Corporate partners: One undisclosed...
08:00 , Nov 16, 1998 |  BioCentury  |  Finance

Testing the IPO waters

Testing the IPO waters MARKET HOPEFULS: Sensus Drug Development (Proposed:SDDC) is planning a 3 million share IPO at $13-$15 per share. A $14 price would value the company at $134.4 million. The underwriters - Merrill...
07:00 , Apr 27, 1998 |  BioCentury  |  Finance

Rothschild's consolidation play

With more than 2500 entrepreneurial bioscience companies now thought to exist - about 1300 in the U.S., 1000 in Europe and a couple of hundred elsewhere - there is the question of how many of...
07:00 , Jul 29, 1996 |  BioCentury  |  Emerging Company Profile

CombiChem Inc.

CombiChem Inc. San Diego, Calif. Technology: Combinatorial chemistry Disease focus: N/A Clinical status: N/A Founded: 1994 by Sydney Brenner, Dale Boger, Kim Janda, Chi-Huey Wong, Sequoia Capital and Forward Ventures Corporate partners: Teijin Ltd. and...
07:00 , Jun 10, 1996 |  BioCentury  |  Finance

Waiting for the bell

Faced by a majority of bullish analyst comments vs. one very negative and well publicized review by Smith Barney of Cephalon's Myotrophin for amyotrophic lateral sclerosis, investors dumped shares of CEPH and partner Chiron (CHIR)...
08:00 , Dec 5, 1994 |  BioCentury  |  Strategy

IntraBiotics plans to run lean

Noteworthy IntraBiotics plans to run lean IntraBiotics Pharmaceuticals Inc. was to announce today that it has raised $4 million in its first round financing, led by the Sprout Group. Other investors in the latest entrant...